| Mathematics and Statistics | 2021-2025 | 193 | US 31 | 98.60 |
| Infectious Diseases | Lifetime | 155 | US 82 | 99.48 |
| Statistics and Probability | Lifetime | 552 | US 301 | 95.49 |
| Virology | Lifetime | 297 | US 169 | 93.66 |
| Statistics, Probability and Uncertainty | Lifetime | 881 | US 342 | 89.26 |
| Statistics and Probability | 2021-2025 | 33 | US 13 | 98.19 |
| Infectious Diseases | 2021-2025 | 224 | US 87 | 96.17 |
| General Health Professions | 2021-2025 | 552 | US 194 | 95.64 |
| Statistics, Probability and Uncertainty | 2021-2025 | 162 | US 28 | 91.29 |
| HIV/AIDS Research and Interventions | Lifetime | 90 | US 58 | 99.67 |
| HIV/AIDS Impact and Responses | Lifetime | 33 | US 10 | 98.73 |
| HIV Research and Treatment | Lifetime | 282 | US 182 | 99.20 |
| HIV/AIDS drug development and treatment | Lifetime | 226 | US 124 | 99.11 |
| HIV, Drug Use, Sexual Risk | Lifetime | 161 | US 98 | 98.85 |
| HIV-related health complications and treatments | Lifetime | 221 | US 131 | 98.01 |
| Advanced Causal Inference Techniques | Lifetime | 100 | US 72 | 96.53 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 527 | US 227 | 97.40 |
| Meta-analysis and systematic reviews | Lifetime | 787 | US 247 | 91.65 |
| Statistical Methods in Epidemiology | Lifetime | 26 | US 11 | 83.54 |
| Reliability and Agreement in Measurement | Lifetime | 699 | US 264 | 59.59 |
| HIV/AIDS Research and Interventions | 2021-2025 | 89 | US 41 | 98.55 |
| Advanced Causal Inference Techniques | 2021-2025 | 15 | US 7 | 97.26 |
| HIV, Drug Use, Sexual Risk | 2021-2025 | 180 | US 91 | 96.19 |
| HIV-related health complications and treatments | 2021-2025 | 259 | US 111 | 90.26 |
| Meta-analysis and systematic reviews | 2021-2025 | 181 | US 29 | 90.51 |
| HIV/AIDS drug development and treatment | 2021-2025 | 791 | US 259 | 84.00 |
| HIV/AIDS Impact and Responses | 2021-2025 | 158 | US 37 | 79.26 |
| Statistical Methods and Bayesian Inference | 2021-2025 | 598 | US 183 | 70.83 |
| Statistical Methods in Clinical Trials | 2021-2025 | 867 | US 364 | 69.20 |
| Reliability and Agreement in Measurement | 2021-2025 | 113 | US 24 | 46.38 |